UM Ventures News UM Ventures News Partner News Technical.ly Baltimore: UMB, in partnership with alumni, wants to commercialize rare disease treatmentsWednesday, August 3, 2022 GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens PipelineTuesday, July 26, 2022 Published Study Results Demonstrate Substantial Length of Stay and Hospital Cost Reductions with Use of CoapTech's PUMA-G System™ for Gastrostomy When Compared to Usual Care MethodsWednesday, May 11, 2022 Technical.ly Baltimore: From nanosensors to vaccines, these creations won UMD’s Invention of the Year awardsThursday, May 5, 2022 BioBuzz: Baltimore Medtech Sector a Key Asset for Ascending Biotech ClusterWednesday, April 20, 2022 Xcision Announces Start of Breast Cancer Treatments Using GammaPod™ Stereotactic Radiotherapy System at Leading Italian HospitalThursday, April 14, 2022 Technical.ly Baltimore: CoapTech prepares clinical trials for its ultrasound-based deviceFriday, March 11, 2022 Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic spaceTuesday, March 8, 2022 CoapTech Announces IDE Approval from FDA to Initiate Clinical Trial for its PUMA-G Peds System for Pediatric GastrostomyTuesday, March 8, 2022 Technology Transfer Tactics: UMB New Venture Group’s model succeeds in boosting region’s start-up ecosystemMonday, March 7, 2022 Pages ‹ 1 2 3 4 5 6 7 8 9 … ›